BALAMINES Balaji Amines Q2 FY25 results (Jul–Sep 2024) and concall
Balaji Amines reported a steady Q2 FY25 performance with consolidated revenue of INR 356 crores and EBITDA margins improving to 20% QoQ, despite a challenging pricing environment. The company successfully commissioned its Methyl Amine plant, doubling capacity, and made significant progress on other strategic projects including DMC, Propylene Glycol, DME, Isopropyl Amines, N-Methyl Morpholine, and a 20MW solar power plant. Management expects 10-12% standalone volume growth for FY25 and aims for INR 3,000-4,000 crores in revenue within 2-2.5 years, driven by new capacities and product diversific
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 |
|---|---|
| Revenue | 347 |
| EBITDA | 61 |
| Net profit | 41 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
